Home » Oxford Genome Sciences Advances on Amgen Deal
Oxford Genome Sciences Advances on Amgen Deal
Oxford Genome Sciences has taken a step closer to shedding its service provider skin and morphing into a pharma firm after entering a new cancer collaboration with Amgen, one of the world's largest biotech firms.
OutsourcingPharma
OutsourcingPharma
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May